South Africa stalls AstraZeneca vaccine campaign after trial found “minimal protection” against new strain

South Africa’s rollout of AstraZeneca’s Covid-19 vaccine has been put on pause following reports that it only provides “minimal protection” for the new strain of the virus first detected in South Africa. The country will continue plans to administer the Pfizer-BioNTech vaccine and the Johnson & Johnson vaccine. The AstraZeneca vaccine, developed in partnership with Oxford University, only provides limited protection against the mild variant of Covid-19 detected in South Africa known as B.1.351, according to early data from a trial. South Africa Minister of Health Zweli Mkhize says immunisations using the AstraZeneca vaccine would be put on hold while […]

The post South Africa stalls AstraZeneca vaccine campaign after trial found “minimal protection” against new strain appeared first on The Thaiger News.

Read more…